Status:
UNKNOWN
Postprandial Glucose Response Using Mass-Market No-Added-Sugar Ice Cream
Lead Sponsor:
Dasman Diabetes Institute
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
KDD is developing a new line of no-added-sugar products in line with its metabolic reengineering initiative and its metabolic matrix. The recipes fundamentally do not alter total saturated fat or prot...
Detailed Description
The consumption of highly ultra-processed foods has been identified as having detrimental effects on human metabolic health, leading to various adverse health outcomes. The Metabolic Matrix represents...
Eligibility Criteria
Inclusion
- Type 2 diabetes
- Aged over 18 years
- HbA1c 6.5-8.5% (48-69 mmol/L)
Exclusion
- Lactose intolerant
- Not liking chocolate ice cream
Key Trial Info
Start Date :
November 12 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 30 2024
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT06135935
Start Date
November 12 2023
End Date
January 30 2024
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ebaa Al Ozairi
Kuwait City, Dasman, Kuwait, 15462